- Home
- CNMD vs KYMR Comparison
CNMD vs KYMR Comparison
Compare CNMD & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNMD
- KYMR
- Stock Information
- Founded
- CNMD 1970
- KYMR 2015
- Country
- CNMD United States
- KYMR United States
- Employees
- CNMD N/A
- KYMR N/A
- Industry
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- CNMD Health Care
- KYMR Health Care
- Exchange
- CNMD Nasdaq
- KYMR Nasdaq
- Market Cap
- CNMD 2.2B
- KYMR 2.7B
- IPO Year
- CNMD 1987
- KYMR 2020
- Fundamental
- Price
- CNMD $61.12
- KYMR $36.81
- Analyst Decision
- CNMD Buy
- KYMR Buy
- Analyst Count
- CNMD 5
- KYMR 15
- Target Price
- CNMD $77.20
- KYMR $55.27
- AVG Volume (30 Days)
- CNMD 513.0K
- KYMR 456.1K
- Earning Date
- CNMD 02-05-2025
- KYMR 02-27-2025
- Dividend Yield
- CNMD 1.33%
- KYMR N/A
- EPS Growth
- CNMD 108.33
- KYMR N/A
- EPS
- CNMD 4.25
- KYMR N/A
- Revenue
- CNMD $1,307,015,000.00
- KYMR $87,563,000.00
- Revenue This Year
- CNMD $8.95
- KYMR N/A
- Revenue Next Year
- CNMD $6.60
- KYMR $32.89
- P/E Ratio
- CNMD $14.38
- KYMR N/A
- Revenue Growth
- CNMD 5.00
- KYMR 86.92
- 52 Week Low
- CNMD $59.50
- KYMR $29.24
- 52 Week High
- CNMD $86.96
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- CNMD 33.20
- KYMR 42.51
- Support Level
- CNMD $61.70
- KYMR $36.67
- Resistance Level
- CNMD $65.50
- KYMR $38.24
- Average True Range (ATR)
- CNMD 2.66
- KYMR 1.78
- MACD
- CNMD -0.74
- KYMR 0.06
- Stochastic Oscillator
- CNMD 10.63
- KYMR 51.81
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.